The Journal of Steroid Biochemistry and Molecular Biology 2014-07-01

Prevention and treatment of postmenopausal osteoporosis

Sri Harsha Tella, J. Christopher Gallagher

Index: J. Steroid Biochem. Mol. Biol. 142 , 155-70, (2014)

Full Text: HTML

Abstract

• ET/HT is first choice for osteoporosis prevention in women <10 years of menopause. • Bisphosphonates is first choice for osteoporosis in older women ≥60 years. • SERMs are an alternative for women who cannot take bisphosphonates or HT/ET.

Related Compounds

  • pTH (1-34) (human...
  • Salmon Calcitonin...
  • Alendronate sodium

Related Articles:

Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OA.

2015-01-01

[Arthritis. Res. Ther. 17 , 315, (2015)]

Protein chemical synthesis by serine and threonine ligation.

2013-04-23

[Proc. Natl. Acad. Sci. U. S. A. 110(17) , 6657-62, (2013)]

Double and quadruple tetracycline labeling of bone: impact of the label itself.

2013-01-01

[J. Bone Miner Res. 28(1) , 222-3, (2013)]

Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosis.

2013-03-01

[J. Bone Miner. Metab. 31(2) , 199-205, (2013)]

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.

2013-01-01

[BMC Musculoskelet. Disord. 14 , 4, (2013)]

More Articles...